CDK inhibitor GSK461364, Purity ≥98%

Cat. No.: X24-05-ZQ690

CDK inhibitor GSK461364, Purity ≥98%

Synonym: 929095-18-1; GSK 461364; GSK-461364; CDK inhibitor

  • CAS Number: 929095-18-1
  • Compound CID: 15983966
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
GSK461364, soluble in DMSO and ethanol and insoluble in water, is an CDK kinase inhibitor that disrupts cell division processes. It targets PLK1.
Molecular Weight
543.6
Molecular Formula
C27H28F3N5O2S
Targets
PLK1: 2.2 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 9 mg/mL (16.55 mM); Water: Insoluble; Ethanol: 27 mg/mL (49.66 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
GSK461364 can be used to study its effects as a Plk1 inhibitor in cancer cell proliferation and survival.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.